Industry Experts - Market Research Reports, Industry Analysis, Custom Research

  Introduction to Biosimilars Biosimilars are biologic drugs that closely resemble approved biologics, known as reference products, without any clinically meaningful differences in terms of safety, purity, or effectiveness. Developed using living systems such as yeast, bacteria, or animal cells, biosimilars are inherently complex and sensitive to manufacturing changes, distinguishing them from generic drugs, which are precise chemical replicas of small-molecule drugs. These products span multiple therapeutic categories, including monoclonal antibodies used in cancer and autoimmune conditions, hematopoietic agents like filgrastim that aid in blood cell production, hormonal treatments such as insulin and growth hormones, and anti-inflammatory medications for conditions like rheumatoid arthritis. Expanding Applications of Biosimilars Biosimilars play a crucial role in managing various diseases, including oncology treatments such as trastuzumab for cancer therapy, blood disorders like...

A new report from Industry Experts Inc, on " Cancer Immunotherapy ," is introduced. As per this market research report, the global market for Cancer Immunotherapy is estimated at US$135.2 billion in 2024 and is anticipated to post a CAGR of 9.8% during the 2024-2030 analysis period and stand at a projected US$236.9 billion by 2030. The global cancer immunotherapy market is primarily driven by the rising prevalence of cancer worldwide, leading to a growing demand for more effective treatment options. Oncolytic viral therapies and cancer vaccines use viruses to specifically target and destroy cancer cells, while Checkpoint inhibitors and CAR-T cell therapies are increasingly employed to treat lung cancer and melanoma. These therapies stimulate immune responses and are gaining attention due to their precise targeting and reduced side effects, further driving market demand. The Monoclonal Antibodies segment dominates the cancer immunotherapy market, holding a proj...